; Whereas, because of the way meningitis is spread through close personal contact, the social behavior of young adults ages 17 to 23 increases their risk of contracting the disease; Whereas students in dormitory settings and crowded events are particularly vulnerable to meningococcal disease; Whereas while vaccines for serogroups A, C, W, and Y have been available for many years, prior to 2014, there were no vaccines available for serogroup B; Whereas despite the existence of a serogroup B vaccine, meningitis B has been responsible for all United States college campus outbreaks since 2011, with some cases resulting in death; Whereas because the B strain of meningitis requires a new, separate vaccination, students heading to college may mistakenly think that if they received the MenACWY vaccine that they are protected against all strains and may not realize they are not protected against the B strain; Whereas according to the Centers for Disease Control and Prevention, Neisseria meningitidis serogroup B accounts for approximately half of all meningococcal cases among persons ages 17 to 23 years in the United States; Whereas vaccination for serogroups A, C, W, and Y is routinely recommended by the Centers for Disease Control and Prevention; Whereas the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) recommends that decisions to vaccinate adolescents and young adults 16 through 23 years of age against serogroup B meningococcal disease should be made at the individual level with health care providers; Whereas meningitis vaccines are covered by public and private insurance plans, and individuals are encouraged to contact their health insurance plan to determine coverage of MenACWY and MenB vaccines